BIVDA’s Head of Regulatory Strategy Professor Mike Messenger was pleased to be involved in a ABPI roundtable examining how regulation can help to unlock the potential of preventative medicines.
During the roundtable, Mike emphasised that the regulatory framework must consider the critical role of diagnostics and the interplay between the two regulatory frameworks, reflecting the partnership working that is needed to improve outcomes in this space.
You can read ABPI’s summary of the event here.
